PharmaEssentia Corp.(TW:6446)
NT$1,335.00+55.00 (+4.30%)
TW:6446
PharmaEssentia Corp. financials statements
NT$1,335.00
At close:+55.00 (+4.30%)
PharmaEssentia Corp. (6446) Financial Statements
PharmaEssentia Corp. Financial Overview
PharmaEssentia Corp.'s market cap is currently NT$528.07B. The company's EPS TTM is NT$19.89; its P/E ratio is 56.35; and it has a dividend yield of 0.11%. PharmaEssentia Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 15.63B | NT$ 9.73B | NT$ 5.11B | NT$ 2.88B | NT$ 656.51M |
| Gross Profit | NT$ 13.68B | NT$ 8.56B | NT$ 4.50B | NT$ 2.07B | NT$ 277.65M |
| Operating Income | NT$ 4.93B | NT$ 1.74B | NT$ -1.91B | NT$ -2.03B | NT$ -2.82B |
| EBITDA | NT$ 5.41B | NT$ 3.38B | NT$ -671.49M | NT$ -1.60B | NT$ -2.57B |
| Net Income | NT$ 5.05B | NT$ 2.97B | NT$ -623.84M | NT$ -1.37B | NT$ -2.81B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 22.72B | NT$ 21.07B | NT$ 19.67B | NT$ 10.30B | NT$ 3.45B |
| Total Assets | NT$ 37.41B | NT$ 31.06B | NT$ 27.27B | NT$ 15.33B | NT$ 6.20B |
| Total Debt | NT$ 856.06M | NT$ 965.47M | NT$ 1.20B | NT$ 1.57B | NT$ 536.31M |
| Net Debt | NT$ -21.86B | NT$ -20.09B | NT$ -18.47B | NT$ -8.73B | NT$ -2.92B |
| Total Liabilities | NT$ 5.44B | NT$ 3.59B | NT$ 3.32B | NT$ 3.19B | NT$ 1.95B |
| Stockholders' Equity | NT$ 31.98B | NT$ 27.47B | NT$ 23.95B | NT$ 12.14B | NT$ 4.25B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 3.37B | NT$ 1.64B | NT$ -2.03B | NT$ -1.83B | NT$ -2.56B |
| Operating Cash Flow | NT$ 5.28B | NT$ 2.55B | NT$ -705.56M | NT$ -1.51B | NT$ -2.46B |
| Investing Cash Flow | NT$ -2.48B | NT$ -1.33B | NT$ -486.65M | NT$ -1.24B | NT$ -78.18M |
| Financing Cash Flow | NT$ -499.94M | NT$ -185.21M | NT$ 10.45B | NT$ 9.58B | NT$ 2.81B |
Currency in TWD

